Skip to main content
Home
  • Global
  • Careers
  • Investors
  • About us
    Fagron company profile

    Activities of Fagron

    Leadership team

    Introduction to members of the Leadership team

    Key figures

    Fagron's key figures in one overview

  • Press
    • Press releases
    • Press kit
  • Publications
    Annual reports

    Please find here our annual reports

    Presentations

    Presentations and conference calls

    Statutory annual accounts

    Please find here the statutory annual accounts

    Prospectus September 2007

    Prospectus of the Initial Public Offering

    Prospectus June 2012

    Prospectus of the 4.75% bond

    Prospectus June 2016

    Prospectus of the capital increase

    Bond

    Compliance certificates and guarantor lists

  • Share
    Share performance

    Look at the actual share performance

    Notification of shareholdings

    Shareholding declaration obligation 

    Dividend

    Dividend policy of Fagron

    Shareholders' meetings

    Documents relating to shareholders' meetings

    Analyst coverage

    Analysts covering Fagron

    Shareholder structure

    Overview of participations

  • Events
    Calendar

    Upcoming events

  • Corporate Governance
    Board of Directors

    Members of the Fagron's Board of Directors

    Leadership team

    Introduction to members of the Leadership team

    Governance documents

    Corporate governance documents

Search form

Go to share performance
  • Shareholders
Print Friendly and PDF
Share by mail

Key figures

Consolidated income statement

(x 1,000 euro) 2019 2018 20171 2016 2015* 2014*
Operating income 536.681 473.395 438.145 425.054 436.182 450.409
Turnover 534.695 471.679 433.529 421.839 427.560 447.056
Other operating income 1.985 1.716 4.616 3.215 8.622 3.353
Operating expenses 452.293 -399.923 -363.538 -407.173 -407.336 -356.073
Trade goods 212.685 -181.253 -167.718 -158.191 -158.316 -158.843
Services and other goods 81.995 -82.144 -76.454 -79.218 -77.535 -76.067
Employee benefit expenses 124.695 -112.573 -100.700 -96.801 -103.839 -101.642
Depreciation and amortisation 29.319 -19.575 -17.550 -21.119 -16.111 -19.025
Impairment - - - -48.364 -47.338 -
Other operating expenses 3.600 -4.379 -1.116 -3.480 -4.197 -496
Operating profit 84.388 73.472 74.607 17.881 28.845 94.336
Financial income 1.682 643 3.154 12.996 2.013 731
Financial expenses -16.183 -19.279 -21.769 -37.242 -46.967 -25.215
Profit before income tax 69.886 54.835 55.965 -6.364 -16.108 69.852
Taxes 14.199 -11.553 -8.918 -11.748 -8.840 -26.663
Net result for the year for continuing operations 55.687 43.282 47.047 -18.112 -24.948 43.190
Net result from discontinuing operations (attributable to shareholders) -14.147 -377 - -2.045 -117.064 -27.033
Net result 41.540 42.905 47.047 -20.157 -202.012 16.156
* Based on continuing operations            
1 The 2017 figures have been adjusted for the application of IFRS 15.            
Profit (loss) for the year per share (in euros) 0,57 0,59 0,65 -0,38 -6,46 0,53
From continuing operations 0,77 0,6 0,65 -0,34 -0,81 1,41
From discontinued operations -0,2 -0,01 0 -0,04 -5,66 -0,88
Diluted profit (loss) for the year per share (in euros) 0,56 0,59 0,65 -0,38 -6,44 0,52
From continuing operations 0,75 0,6 0,65 -0,34 -0,8 1,39
From discontinued operations -0,19 -0,01 0 -0,04 -5,63 -0,87

Consolidated balance sheet

 (x 1,000 euro)                             2019​ 2018 2017 2016 2015 2014*
Non current assets 562.052 483.046 427.617 455.707 501.535   662.649
Intangible fixed assets 418.137 391.388 344.495 371.006 410.601 575.252
Property, plant and equipment 87.606 73.439 69.535 72.879 71.133 59.969
Lease and similar rights 33.601          
Financial assets 4.287 2.158 2.232 2.123 5.859 5.064
Deferred tax assets 18.420 16.061 11.355 9.698 13.942 22.363
Current assets 239.189 199.726 166.430 412.346 187.846 228.114
Inventories 77.479 74.658 62.865 60.054 67.251 65.181
Trade receivables 44.588 38.289 32.220 32.879 34.090 36.337
Other receivables 10.438 9.200 10.574 23.829 11.031 18.043
Restricted funds - - - 220.622 - -
Cash and cash equivalents 106.684 77.579 60.771 74.962 75.474 108.552
Assets held for sale - - - - - 82.989
Total assets 801.240 682.772 594.047 868.053 689.381 973.752
Equity 246.440 209.716 184.881 152.875 -64.772 156.948
Shareholders' equity (parent) 242.028 205.841 181.398 149.792 -67.473 154.630
Non-controlling interest 4.413 3.875 3.483 3.083 2.700 2.317
Non-current liabilities 363.029 285.250 300.925 309.125 27.064 575.472
Provisions 5.653 13.759 12.476 12.776 15.987 8.891
Pension obligations 5.778 5.183 4.733 5.680 5.146 6.053
Deferred tax liabilities 339 259 198 236 1.519 6.162
Borrowings 322.619 265.917 283.518 290.433 4.411 551.504
Lease liabilities  28.189 - - - - -
Financial instruments 451 131 - - - 2.862
Current liabilities 191.771 187.806 108.241 406.053 727.090 220.938
Borrowings 34.119 63.955 13.450 290.559 594.908 5.710
Lease liabilities  6.604 - - - - -
Trade payables 77.303 63.918 58.950 53.163 63.043 57.440
Taxes, remuneration and social security 31.842 31.395 27.168 34.977 25.282 38.668
Other current payables 41.847 28.538 8.673 18.825 41.859 119.120
Financial instruments 56 - - 8.530 1.996 -
Liabilities directly associated with assets classified as held for sale   - - - - 20.394
Total liabilities 554.800 473.056 409.166 715.178 754.154 816.804
Total equity and liabilities 801.240 682.772 594.047 868.053 689.381 973.752
* Based on continuing operations.            

About Fagron

Fagron is the leading global pharmaceutical compounding company, bringing customized pharmaceutical care to hospitals, pharmacies, clinics and patients in 35 countries worldwide.

Press releases

Sign up to receive our latest press releases.

Subscribe

Contact us

  • +31 (0) 88 33 11 200
  • investors@fagron.com

Contact information

© Copyright 2021 Fagron.

  • Disclaimer
  • Privacy Statement